Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05661084 · ClinicalTrials.gov registry record · NA

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

A NA study of Alzheimer Disease and Dementia, sponsored by Hebrew SeniorLife.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT05661084 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Hebrew SeniorLife. The registered enrollment target is 144 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05661084, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Hebrew SeniorLife.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

This project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.

Conditions Studied

Alzheimer Disease Dementia Mobility Limitation Executive Dysfunction Memory Loss

Interventions

  • DEVICE Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active)
  • DEVICE Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (sham)
  • DEVICE Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (sham)
  • DEVICE Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (active)

Study Locations (1)

Massachusetts

  • Hinda and Arthur Marcus Institute for Aging Research - Boston

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2023-01-24
Est. Completion 2027-08-31
Phase NA

Sponsor

Hebrew SeniorLife

32 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05661084

The ClinicalTrials.gov registry entry for NCT05661084 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 4 interventions - of which Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active) is the first listed.

NCT05661084 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05661084 about?

NCT05661084 is a clinical study titled "Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia". This project aims to examine the efficacy of remote, caregiver-led tES/brain stimulation intervention targeted to improve memory, mobility, and executive functioning among older adults with mild cognitive impairment or mild dementia.

What is the current status of trial NCT05661084?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2023-01-24. Estimated completion is 2027-08-31.

What conditions does trial NCT05661084 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Mobility Limitation, Executive Dysfunction, Memory Loss.

What interventions are being tested in trial NCT05661084?

The interventions under investigation include: Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (active) (DEVICE), Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (sham) (DEVICE), Transcranial alternating current stimulation (tACS) (active); Transcranial direct current stimulation (tDCS) (sham) (DEVICE), Transcranial alternating current stimulation (tACS) (sham); Transcranial direct current stimulation (tDCS) (active) (DEVICE).

Who is sponsoring clinical trial NCT05661084?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05661084 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Dementia

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.